|
ITGB8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.575300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.698270E-03 |
| Normal-vs-Stage2 |
6.870400E-01 |
| Normal-vs-Stage3 |
3.279700E-03 |
| Normal-vs-Stage4 |
1.258070E-03 |
| Stage1-vs-Stage2 |
2.702200E-01 |
| Stage1-vs-Stage3 |
6.251000E-01 |
| Stage1-vs-Stage4 |
2.800000E-01 |
| Stage2-vs-Stage3 |
2.043600E-01 |
| Stage2-vs-Stage4 |
1.182810E-01 |
| Stage3-vs-Stage4 |
5.971400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.556800E-04 |
| Normal-vs-AfricanAmerican |
1.159390E-01 |
| Normal-vs-Asian |
4.603200E-01 |
| Caucasian-vs-AfricanAmerican |
5.811800E-01 |
| Caucasian-vs-Asian |
2.195600E-01 |
| AfricanAmerican-vs-Asian |
1.032000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.104600E-03 |
| Normal-vs-Female |
7.64970000000087E-05 |
| Male-vs-Female |
7.296500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.484800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.897800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.822410E-03 |
| Normal-vs-Age(81-100Yrs) |
1.715430E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.613400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.667400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.760800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.923400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.839200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.108000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.492200E-02 |
| Normal-vs-Grade 2 |
1.051920E-02 |
| Normal-vs-Grade 3 |
1.039570E-02 |
| Normal-vs-Grade 4 |
1.38569999996729E-06 |
| Grade 1-vs-Grade 2 |
5.830400E-01 |
| Grade 1-vs-Grade 3 |
5.542800E-01 |
| Grade 1-vs-Grade 4 |
4.570400E-01 |
| Grade 2-vs-Grade 3 |
9.888000E-01 |
| Grade 2-vs-Grade 4 |
5.022500E-03 |
| Grade 3-vs-Grade 4 |
8.835300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.814600E-04 |
| Normal-vs-ccB subtype |
2.825800E-01 |
| ccA subtype-vs-ccB subtype |
5.450100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.643600E-02 |
| Normal-vs-N1 |
5.611800E-01 |
| N0-vs-N1 |
3.047600E-01 |
|
|
